Merlin, a tumor suppressor, interacts with transactivation-responsive RNA-binding protein and inhibits its oncogenic activity
about
Disease-causing mutations in parkin impair mitochondrial ubiquitination, aggregation, and HDAC6-dependent mitophagyTRBP, a regulator of cellular PKR and HIV-1 virus expression, interacts with Dicer and functions in RNA silencingDifferential roles of human Dicer-binding proteins TRBP and PACT in small RNA processingSmall interfering RNAs against the TAR RNA binding protein, TRBP, a Dicer cofactor, inhibit human immunodeficiency virus type 1 long terminal repeat expression and viral productionMerlin, a "magic" linker between extracellular cues and intracellular signaling pathways that regulate cell motility, proliferation, and survivalHDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagyNeurofibromatosis type 2.TRBP ensures efficient Dicer processing of precursor microRNA in RNA-crowded environments.Characterization of the TRBP domain required for dicer interaction and function in RNA interference.MFN1 deacetylation activates adaptive mitochondrial fusion and protects metabolically challenged mitochondria.Structural determinants of Arabidopsis thaliana Hyponastic leaves 1 function in vivo.The multiple functions of TRBP, at the hub of cell responses to viruses, stress, and cancer.TRBP alters human precursor microRNA processing in vitro.Uncoupling of Protein Aggregation and Neurodegeneration in a Mouse Amyotrophic Lateral Sclerosis Model.Protein interactions and complexes in human microRNA biogenesis and function.Clinical and functional impact of TARBP2 over-expression in adrenocortical carcinomaTRBP control of PACT-induced phosphorylation of protein kinase R is reversed by stress.Protein components of the microRNA pathway and human diseases.Clinicopathological Significance of TARBP2, APP, and ZNF395 in Breast Cancer.Dissecting the roles of TRBP and PACT in double-stranded RNA recognition and processing of noncoding RNAs.Merlin facilitates ubiquitination and degradation of transactivation-responsive RNA-binding protein.The efficacy of lapatinib and nilotinib in combination with radiation therapy in a model of NF2 associated peripheral schwannoma.The cellular TAR RNA binding protein, TRBP, promotes HIV-1 replication primarily by inhibiting the activation of double-stranded RNA-dependent kinase PKR.A Rapid Induction Mechanism for Lin28a in Trophic Responses.Specific residues at every third position of siRNA shape its efficient RNAi activityThe merlin tumor suppressor interacts with Ral guanine nucleotide dissociation stimulator and inhibits its activity.Role of microRNAs and microRNA machinery in the pathogenesis of diffuse large B-cell lymphoma.Functional Redundancy of DICER Cofactors TARBP2 and PRKRA During Murine Embryogenesis Does Not Involve miRNA Biogenesis.Update from the 2011 International Schwannomatosis Workshop: From genetics to diagnostic criteria.Neurofibromatosis Type 2.Increased interaction between PACT molecules in response to stress signals is required for PKR activation.
P2860
Q24311582-30890F77-83E4-4D33-AEBF-588B506FAF02Q24320260-F6DB6270-BE19-4F79-AACA-844E3B6723EEQ24339591-DC989960-3B1B-4DB2-9280-E9B08A6C0943Q24682936-2FD9B5BD-9E9E-4FA9-8497-56155F244950Q28283076-9D8043E0-3497-456B-B8F7-FE7AFF0833DAQ30014829-0CC4E07D-DC21-47BA-A426-13BD1055CA5AQ30391375-A5348E58-C408-4BBA-A85C-C5BBDC58D822Q30831870-FDFE0B70-4DF4-4E5D-B3AC-4C5DE1B86236Q33440877-495FC6CA-DC4B-41F7-A364-6030D36192DFQ34507648-508DC71A-87FB-4C67-B3C4-B4819E41C172Q35436596-AF94012E-66F5-4C44-A4EE-D7C67EC56196Q36194939-9D2EFF3B-7474-493B-A749-A5BD58DA8922Q36342240-FC63957B-6653-47D4-8AC2-E48BDF705BF5Q36727035-A48D5C7C-2FC1-418E-8162-FE023F59925CQ36992495-5EE1F900-5C25-4B59-9A75-FED2BA24F5BAQ37006838-A339DB58-4D75-401D-8A31-92AB11FD7617Q37033570-491F5517-C391-4ED0-9741-9E35CA2D80ECQ37419315-6EEEF24F-E55C-499A-93A6-D35B29DCA090Q37488991-4E933A03-62F4-461A-813E-50C90BBB8135Q38335714-83F24F49-2F57-4FAB-813F-C68F689A218BQ38512574-1B08F68F-AECE-4151-BCCA-C6A47DE88271Q38666243-981A3C1F-7F4D-43D2-9436-40E2A8AABE70Q38960851-F76C23D4-51AB-4CC6-A3AF-DCCAD72EDBBCQ42504892-376AE9A1-7CAB-4ABB-940D-6E3246BB3CE1Q42610466-D2B532C1-F38D-4C60-BAAD-E85EED0BBE31Q42812549-4DC7EFF4-6D07-4BCB-A40B-6C7848B8FA4BQ42923456-79416A6A-4A84-433D-8CAF-5C27F02F7DF4Q52691677-81DABC06-8299-4D4A-9169-9D9B6E28211EQ53116195-2EAEA770-9D1D-4B5B-B8E4-8C31F6B1FAE3Q54191697-BE3B0C8B-7C2D-4FE4-AE52-C485C7E60130Q54519466-363A171B-6CC5-4E4A-86EC-A5F464E479A5
P2860
Merlin, a tumor suppressor, interacts with transactivation-responsive RNA-binding protein and inhibits its oncogenic activity
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Merlin, a tumor suppressor, in ...... nhibits its oncogenic activity
@ast
Merlin, a tumor suppressor, in ...... nhibits its oncogenic activity
@en
Merlin, a tumor suppressor, in ...... nhibits its oncogenic activity
@nl
type
label
Merlin, a tumor suppressor, in ...... nhibits its oncogenic activity
@ast
Merlin, a tumor suppressor, in ...... nhibits its oncogenic activity
@en
Merlin, a tumor suppressor, in ...... nhibits its oncogenic activity
@nl
prefLabel
Merlin, a tumor suppressor, in ...... nhibits its oncogenic activity
@ast
Merlin, a tumor suppressor, in ...... nhibits its oncogenic activity
@en
Merlin, a tumor suppressor, in ...... nhibits its oncogenic activity
@nl
P2093
P2860
P356
P1476
Merlin, a tumor suppressor, in ...... nhibits its oncogenic activity
@en
P2093
Byung Hyune Choi
Chang Rak Choi
Chung Hun Ryu
Hongtae Kim
Hyung Kyun Rha
Jae Young Kim
Joo Yong Lee
Joon-Ki Kang
Kweon-Haeng Lee
Pil-Woo Huh
P2860
P304
P356
10.1074/JBC.M312083200
P407
P577
2004-07-16T00:00:00Z